HormoneFDA Approved

Sermorelin

Subcutaneous injection

Overview

A synthetic 29-amino acid analog of GHRH representing the shortest fully functional fragment of the native 44-amino acid hormone. Sermorelin stimulates the pituitary to produce and release growth hormone through the natural GHRH receptor pathway, preserving the hypothalamic-pituitary feedback axis.

Mechanism of Action

It maintains physiological pulsatile GH secretion patterns..

Research Summary & Key Findings

FDA-approved for diagnostic evaluation and treatment of growth hormone deficiency in children. Clinical studies demonstrated increases in GH secretion, lean body mass, and improvements in body composition. Shown to improve sleep quality through enhanced slow-wave sleep.

Clinical Status

FDA Approved

Sermorelin has received FDA approval and is available for clinical use under appropriate medical supervision. Consult a qualified healthcare provider for prescribing information.

Administration Routes

Subcutaneous injection

Related Peptides in Hormone

Find a Provider

Find a verified provider who offers Sermorelin therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Sermorelin.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.